The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis

Predicting High Vancomycin Minimum Inhibitory Concentration in Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

(2011) A. S. Lubin et al.   CLINICAL INFECTIOUS DISEASES

Vancomycin: We Can't Get There From Here

(2011) N. Patel et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets

(2011) R. Kullar et al.   CLINICAL INFECTIOUS DISEASES

Can clinical and molecular epidemiologic parameters guide empiric treatment with vancomycin for methicillin-resistant Staphylococcus aureus infections?

(2011) Jason Yamaki et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia

(2011) Eun Young Choi et al.   INTENSIVE CARE MEDICINE

Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia

(2011) R. Khatib et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Performance of Various Testing Methodologies for Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus in Bloodstream Isolates

(2011) S. J. van Hal et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations

(2011) Natasha E. Holmes et al.   JOURNAL OF INFECTIOUS DISEASES

Vancomycin Minimum Inhibitory Concentration and Outcome in Patients With Staphylococcus aureus Bacteremia: Pearl or Pellet?

(2011) T. L. Holland et al.   JOURNAL OF INFECTIOUS DISEASES

Clinical Characteristics and Risk Factors for Mortality in Patients with Meningitis Caused by Staphylococcus aureus and Vancomycin Minimal Inhibitory Concentrations Against These Isolates

(2011) Wen-Chi Huang et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Vancomycin Heteroresistance Is Associated with Reduced Mortality in ST239 Methicillin-Resistant Staphylococcus aureus Blood Stream Infections

(2011) Sebastiaan J. van Hal et al.   PLoS One

Vancomycin MIC Susceptibility Testing of Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Isolates: A Comparison Between Etest® and an Automated Testing Method

(2011) Christopher M. Bland et al.   SOUTHERN MEDICAL JOURNAL

Increased Mortality with Accessory Gene Regulator (agr) Dysfunction inStaphylococcus aureusamong Bacteremic Patients

(2010) Marin L. Schweizer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-IntermediateStaphylococcus aureusIsolates

(2010) Sebastiaan J. van Hal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: Mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method

(2010) Jiun-Ling Wang et al.   BMC INFECTIOUS DISEASES

Relationship of Vancomycin Minimum Inhibitory Concentration to Mortality in Patients With Methicillin-Resistant Staphylococcus aureus Hospital-Acquired, Ventilator-Associated, or Health-care-Associated Pneumonia

(2010) Nadia Z. Haque et al.   CHEST

Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection

(2010) G. Ralph Corey et al.   CLINICAL INFECTIOUS DISEASES

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

(2010) E. Rubinstein et al.   CLINICAL INFECTIOUS DISEASES

Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies

(2010) Rebecca A. Keel et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia

(2010) Elizabeth A. Neuner et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

The importance of a judicious and early empiric choice of antimicrobial for methicillin-resistant Staphylococcus aureus bacteraemia

(2010) N. Shime et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient—a review of the literature

(2010) S. J. van Hal et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK

(2010) Tom Lewis et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin

(2010) Y. K. Yoon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan

(2010) S.-H. Lin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical Characteristics, Outcomes, and Microbiologic Features Associated with Methicillin-ResistantStaphylococcus aureusBacteremia in Pediatric Patients Treated with Vancomycin

(2010) Kerry J. Welsh et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical characteristics of vancomycin minimum inhibitory concentration of 2μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia

(2010) Yoshio Takesue et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA

(2009) K. C. Horne et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Paradoxical Relationship between the Clinical Outcome ofStaphylococcus aureusBacteremia and the Minimum Inhibitory Concentration of Vancomycin

(2009) James Price et al.   CLINICAL INFECTIOUS DISEASES

Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection

(2009) T. Ferry et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years

(2009) A. C. Musta et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Heterogeneous Vancomycin‐Intermediate Susceptibility Phenotype in Bloodstream Methicillin‐ResistantStaphylococcus aureusIsolates from an International Cohort of Patients with Infective Endocarditis: Prevalence, Genotype, and Clinical Significance

(2009) In‐Gyu Bae et al.   JOURNAL OF INFECTIOUS DISEASES

Clinical Features of Heteroresistant Vancomycin-IntermediateStaphylococcus aureusBacteremia versus Those of Methicillin-ResistantS. aureusBacteremia

(2009) Yasmin Maor et al.   JOURNAL OF INFECTIOUS DISEASES

Is High Vancomycin Minimum Inhibitory Concentration a Good Marker to Predict the Outcome of Methicillin‐ResistantStaphylococcus aureusBacteremia?

(2009) Antonio Lalueza et al.   JOURNAL OF INFECTIOUS DISEASES

Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin

(2008) T. P. Lodise et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin Minimum Inhibitory Concentration as a Predictor of Mortality in Methicillin‐ResistantStaphylococcus aureusBacteremia: A Second Look

(2008) Adam D. Porath et al.   CLINICAL INFECTIOUS DISEASES

Methicillin-resistant Staphylococcus aureus bacteraemia and mortality in a teaching hospital

(2008) C. J. Beeston et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Outcome of patients with meticillin-resistant Staphylococcus aureus bacteraemia at an emergency department of a medical centre in Taiwan

(2008) Chun-Hsing Liao et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections

(2008) Donald I. Hsu et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

(2007) A. Soriano et al.   CLINICAL INFECTIOUS DISEASES